Celastrol is a naturally occurring compound extracted from the root bark of Tripterygium wilfordii Hook F., a plant commonly known as thunder god vine, which has been used in traditional Chinese medicine for centuries to treat inflammatory conditions. It belongs to a chemical class called quinone methide triterpenoids and was first isolated from the plant in 1936.1PubMed. Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone-methide triterpenoid celastrol Over the past two decades, celastrol has attracted serious scientific attention for effects that span weight loss, cancer cell death, neuroprotection, and autoimmune disease, but the gap between laboratory promise and clinical reality remains wide.
Where Celastrol Comes From
Thunder god vine is a climbing plant native to southern China, and its root extracts have long been prescribed in traditional Chinese medicine for rheumatoid arthritis and other inflammatory conditions. More than 100 bioactive compounds have been isolated from the plant, but celastrol and another molecule called triptolide are considered the two most pharmacologically important.2PubMed Central. The main anticancer bullets of the Chinese medicinal herb, thunder god vine Celastrol has also been found in a related species, Celastrus orbiculatus, which is sometimes called Oriental bittersweet.3PubMed. Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid
One reason celastrol stands out among the many compounds in thunder god vine is its broad pharmacological reach. Where triptolide has strong immunosuppressive and anti-tumor effects but severe toxicity that limits its therapeutic window, celastrol has been described as one of the most promising medicinal molecules isolated from traditional plant medicines, with a profile that researchers view as more tractable for drug development.4PubMed. Celastrol: Molecular targets of Thunder God Vine
How Celastrol Works at a Molecular Level
Celastrol does not have one clean mechanism. It hits several molecular targets at once, which is both the source of its broad therapeutic potential and the reason it is so difficult to develop into a conventional drug. The three best-studied pathways help explain why it keeps appearing in such different areas of medical research.
The first and most heavily investigated target is a signaling hub called NF-κB, which acts as a master switch for inflammation. When NF-κB is overactive, it drives chronic inflammation, helps tumor cells resist death, and promotes tissue damage in autoimmune diseases. Celastrol suppresses NF-κB activation at multiple points in the chain, blocking the enzymes that would normally flip the switch on.5PubMed. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation This single mechanism helps explain why celastrol shows anti-inflammatory, anti-cancer, and organ-protective effects simultaneously.
The second target is Hsp90, a protein that acts as a chaperone, helping hundreds of other proteins fold correctly and stay functional. Many of those client proteins are ones that cancer cells depend on to grow and survive. Celastrol disrupts Hsp90’s ability to pair up with a partner protein it needs to function, and it does so through a different binding site than older Hsp90 inhibitors use.6PubMed Central. Characterization of celastrol to inhibit hsp90 and cdc37 interaction This makes celastrol interesting as a potential complement to existing drugs, because it may bypass resistance mechanisms that block other Hsp90 inhibitors.
The third mechanism involves reactive oxygen species, or ROS. At the right doses, celastrol ramps up ROS inside cells, which in healthy tissue is damaging but in cancer cells can trigger a chain of events leading to cell death. In gastric cancer cell lines, this ROS burst appeared within 15 minutes of exposure, and when researchers added an antioxidant to neutralize the ROS, celastrol’s cancer-killing effect disappeared.7PubMed Central. Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells The same ROS-dependent mechanism has been observed in drug-resistant colon cancer cells and in glioma cells.8PubMed Central. Prooxidative Activity of Celastrol Induces Apoptosis, DNA Damage, and Cell Cycle Arrest in Drug-Resistant Human Colon Cancer Cells9PubMed Central. Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells
The Obesity and Weight Loss Research
If celastrol is known for one thing in popular health circles, it is the weight-loss data in mice. A landmark 2015 study published in Cell reported that celastrol caused up to 45% weight loss in obese mice that had been fed a high-fat diet. The compound worked by restoring the animals’ sensitivity to leptin, the hormone that tells the brain the body has enough fat stored and should stop eating. Crucially, celastrol had no effect in mice that lacked leptin or its receptor, confirming that the weight loss depended entirely on the leptin pathway.10PubMed Central. Treatment of obesity with celastrol
Those results generated enormous media attention, and for good reason: leptin resistance is considered one of the core problems in human obesity. The body produces plenty of leptin, but the brain stops responding to it, so appetite stays high even when fat stores are large. A drug that could restore that sensitivity would, in theory, reset the appetite thermostat rather than just suppressing hunger through brute pharmacological force.
Follow-up research added another dimension. In aged mice, celastrol induced weight loss even though it had no effect in younger controls, and it reduced fasting blood sugar while lowering food intake.11PubMed Central. The leptin sensitizer celastrol reduces age-associated obesity and modulates behavioral rhythms This age-dependent effect makes a certain biological sense: leptin sensitivity tends to deteriorate with age, so there may be more room for a sensitizer to work in older animals. But all of this remains in the animal model stage. No large human obesity trial with celastrol has been completed, and the challenge of translating mouse weight-loss results to people has humbled plenty of promising compounds before.
Potential in Autoimmune and Inflammatory Disease
The traditional use of thunder god vine for rheumatoid arthritis is probably the longest-running human evidence base for celastrol’s parent plant, though the crude root extracts contain many compounds beyond celastrol itself. Isolating celastrol’s specific contribution is a more recent effort. In rat models of arthritis, celastrol treatment reduced joint swelling, lowered arthritis severity scores, and decreased the infiltration of inflammatory cells into synovial tissue.12PubMed. Celastrol inhibits rheumatoid arthritis through the ROS-NF-κB-NLRP3 inflammasome axis Another study found that celastrol inhibited the proliferation of synovial fibroblasts, the cells that form the aggressive tissue overgrowth characteristic of rheumatoid arthritis, through a pathway involving autophagy.13PubMed. Celastrol inhibits rheumatoid arthritis by inducing autophagy via inhibition of the PI3K/AKT/mTOR signaling pathway
Beyond the joints, celastrol’s anti-inflammatory properties have shown kidney-protective effects in animal models of diabetic kidney disease. In one study using a mouse model of type 2 diabetes, celastrol improved insulin resistance, blood sugar control, and kidney function, while reducing the production of inflammatory signaling molecules in kidney tissue.14PubMed Central. Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice These organ-protective effects probably stem from the same NF-κB inhibition described earlier, but they point to applications well beyond the autoimmune diseases the plant was traditionally used for.
Cancer Research Findings
Celastrol appears in cancer research for three overlapping reasons. It can trigger cancer cell death through the ROS mechanism already described. It can make cancer cells more sensitive to conventional chemotherapy drugs. And through Hsp90 disruption and NF-κB inhibition, it can interfere with survival signals that many tumors rely on to resist treatment.
The chemosensitization angle may be the most clinically relevant. Cancer drug resistance is one of the main reasons chemotherapy fails, and celastrol has shown the ability to re-sensitize resistant cells to the drugs they were shrugging off. This has been studied across a range of tumor types, and the underlying idea is not that celastrol would replace chemotherapy but that it could be used alongside existing drugs to restore their effectiveness.15Academic Press. Role of Celastrol in Chemosensitization of Cancer In drug-resistant colon cancer cells, for instance, celastrol above a concentration of about 1 micromolar increased ROS at both the cellular and mitochondrial level, leading to DNA damage and cell death in cells that had previously survived treatment.8PubMed Central. Prooxidative Activity of Celastrol Induces Apoptosis, DNA Damage, and Cell Cycle Arrest in Drug-Resistant Human Colon Cancer Cells
The important caveat: nearly all cancer data for celastrol comes from cell lines and animal models. Cancer researchers frequently identify compounds that kill tumor cells in a dish but fail in the body, whether because the compound cannot reach the tumor in high enough concentrations, because it damages healthy tissue at effective doses, or simply because human tumors behave differently from lab-grown cell lines. Celastrol’s poor bioavailability, discussed below, makes this gap particularly wide.
Neuroprotective Effects
Neurodegenerative diseases like Parkinson’s and Alzheimer’s involve chronic brain inflammation and the accumulation of damaged proteins and mitochondria. Celastrol’s ability to reduce inflammation and activate autophagy, the cellular cleanup process that degrades dysfunctional components, has made it a subject of increasing interest in neuroscience.
In mouse models of Parkinson’s disease, celastrol protected dopamine-producing neurons from dying, reduced neuroinflammation, and improved motor symptoms. One study found that celastrol achieved this by activating mitophagy, a specialized form of autophagy that targets damaged mitochondria for destruction, essentially helping neurons clear out the dysfunctional energy factories that would otherwise trigger cell death.16PubMed Central. Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson’s Disease through Activating Mitophagy A separate study using a different Parkinson’s model showed that celastrol’s neuroprotection worked through a pathway that dampens the inflammatory cascade while simultaneously activating antioxidant defenses in the brain.17PubMed Central. The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson’s disease
A 2025 review paper positioned celastrol as a compound with promising neuroprotective effects across Parkinson’s disease, Alzheimer’s disease, and spinal cord injury, noting that its effects converge on reducing inflammation, activating autophagy, and inhibiting a form of cell death driven by iron accumulation called ferroptosis.18International Immunopharmacology. Celastrol as a neuroprotective drug: current status and challenges As with the cancer research, these are animal and cell-based findings. No human clinical trial has tested celastrol specifically for any neurodegenerative condition.
Side Effects and Safety Concerns
The same biological aggressiveness that makes celastrol interesting as a drug candidate also makes it risky. Thunder god vine root extracts used in clinical settings have produced substantial gastrointestinal side effects, including nausea, diarrhea, and abdominal pain.19PubMed Central. Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases These reports involve crude extracts rather than purified celastrol, but celastrol itself is not benign.
One area of concern is reproductive toxicity. A study examining the effects of Tripterygium glycosides on testicular tissue identified celastrol as the most toxic component to spermatogonia, the cells that give rise to sperm. Celastrol induced excessive autophagy in these cells, meaning it triggered the same cleanup process that protects neurons in the brain but turned it destructive in reproductive tissue.20PubMed. Celastrol induced the autophagy of spermatogonia cells contributed to tripterygium glycosides-related testicular injury This finding is a stark reminder that mechanisms beneficial in one tissue can be harmful in another, and it underscores why celastrol cannot simply be taken as a supplement and assumed safe.
Other documented concerns from preclinical work include liver stress at higher doses and the narrow window between therapeutic and toxic concentrations. The compound’s multi-target nature, hitting NF-κB, Hsp90, and ROS generation all at once, means that cranking up the dose in pursuit of one effect can trigger unwanted consequences through the others. This is a pharmacological double-edged sword that drug developers have to solve before celastrol can move into widespread human use.
The Bioavailability Problem
Perhaps the single biggest obstacle to turning celastrol into a medicine is that it does not get absorbed well when taken by mouth. In rats, oral celastrol was poorly absorbed into the bloodstream, which means that even if the compound does everything the lab studies suggest, getting enough of it to the right tissues in a living person is an unsolved engineering problem.21PubMed. Oral bioavailability and gender-related pharmacokinetics of celastrol following administration of pure celastrol and its related tablets in rats It also has low water solubility, which compounds the absorption issue and makes it difficult to formulate as a conventional pill.
Researchers have been working on this from multiple angles. Nanotechnology-based delivery systems, including nanoparticles, liposomes, and polymer-drug conjugates, are the most widely explored strategy for getting celastrol into the body at therapeutic concentrations while limiting its toxicity to healthy tissues.22PubMed Central. Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications Some of these delivery vehicles are designed to release celastrol preferentially in tumor tissue or at sites of inflammation, which could widen the therapeutic window by keeping concentrations low everywhere else. This is still early-stage work, but it represents the kind of pharmaceutical engineering that would need to succeed before celastrol-based drugs reach clinical trials in most disease areas.
Why You Cannot Buy Celastrol as a Regulated Drug
Given the volume of positive preclinical data, it is reasonable to wonder why celastrol is not already available as a prescription medication. Several barriers have kept it in the lab. The poor oral bioavailability means that a straightforward pill formulation does not work. The toxicity profile, especially at higher doses and with chronic use, narrows the margin between helpful and harmful. And while celastrol hits many disease-relevant targets, that promiscuity also makes side effects harder to predict and manage in humans.
Clinical trials with purified celastrol remain limited. The most extensive human data come from trials using whole thunder god vine extracts for conditions like rheumatoid arthritis and kidney disease, but those extracts contain many active compounds, making it impossible to attribute specific effects to celastrol alone. The solubility, bioavailability, and dosing challenges that still limit celastrol’s clinical application have been flagged by researchers as the central hurdles to overcome.19PubMed Central. Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases
You can find celastrol sold as a dietary supplement online, typically marketed for joint health or weight loss. These products are not regulated the way drugs are, and there is no guarantee of purity, dose accuracy, or safety. Given the reproductive toxicity findings and the narrow therapeutic window, self-dosing with unregulated celastrol carries real risks that go beyond the vague “consult your doctor” disclaimer.
Making Celastrol Without the Plant
Thunder god vine is a slow-growing plant, and celastrol makes up a small fraction of the root bark. Harvesting enough for research purposes, let alone pharmaceutical production, is neither efficient nor ecologically sustainable. This supply problem has driven a parallel line of research into producing celastrol through biotechnology.
A major breakthrough came in 2023, when researchers published the complete biosynthetic pathway for celastrol and demonstrated that they could produce it in engineered yeast starting from table sugar. The team elucidated 11 previously unknown enzymatic steps in the pathway, including a surprising non-enzymatic chemical cascade that generates celastrol’s characteristic structural feature.23PubMed. Biosynthesis and biotechnological production of the anti-obesity agent celastrol Earlier work had laid the groundwork by producing a celastrol precursor called polpunonic acid in yeast, establishing the feasibility of the approach.24PubMed Central. Integrating pathway elucidation with yeast engineering to produce polpunonic acid the precursor of the anti-obesity agent celastrol
This matters for two reasons. If celastrol does eventually become a drug, a yeast-based production method could supply it at scale without stripping bark from wild plants. And the ability to produce celastrol in a controlled fermentation system gives researchers a much cleaner starting material for formulation work, free of the dozens of other bioactive compounds present in crude plant extracts. Whether the yeast system can be scaled to pharmaceutical production levels is still an open question, but the biochemistry is now solved.
How Celastrol Compares to Other Thunder God Vine Compounds
Celastrol is often discussed alongside triptolide, the other headline compound from thunder god vine. Both are potent, but their profiles differ in ways that affect their chances of becoming drugs. Triptolide is a diterpenoid epoxide with extremely strong anti-cancer and immunosuppressive effects, but its toxicity is severe enough that it has proven very difficult to develop safely. The two compounds perturb different signaling pathways and are considered to have divergent therapeutic profiles despite coming from the same plant.2PubMed Central. The main anticancer bullets of the Chinese medicinal herb, thunder god vine
For a general audience, the practical takeaway is that “thunder god vine extract” is not the same thing as celastrol. Crude extracts sold as supplements contain varying amounts of both celastrol and triptolide, along with many other compounds, and the ratio can differ wildly between products and even between batches. Someone drawn to celastrol’s weight-loss or joint-health data should understand that taking a thunder god vine supplement exposes them to a cocktail of compounds with very different safety profiles, not just the one molecule they read about.